Evidence map›Paper›PMID 26370960›Full record

ReviewInternational journal of molecular sciences2015

Physiological Dynamics in Demyelinating Diseases: Unraveling Complex Relationships through Computer Modeling.

Jay S Coggan, Stefan Bittner, Klaus M Stiefel, Sven G Meuth, Steven A Prescott

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. β-carbolines that enhance GABAFrontiers in cellular neuroscience · 2024
    Article
  8. Metabolic implications of axonal demyelination and its consequences for synchronized network activity: AnJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Jay S CogganNeuroLinx Research Institute, La Jolla, CA 92039, USA. jay@neurolinx.org.
Stefan BittnerDepartment of Neurology, Institute of Physiology, Universitätsklinikum Münster, 48149 Münster, Germany. stefan-bittner@outlook.com.
Klaus M StiefelNeuroLinx Research Institute, La Jolla, CA 92039, USA. klaus@neurolinx.org.
Sven G MeuthDepartment of Neurology, Institute of Physiology, Universitätsklinikum Münster, 48149 Münster, Germany. sven.meuth@ukmuenster.de.
Steven A PrescottNeurosciences and Mental Health, the Hospital for Sick Children, Toronto, ON M5G 1X8, Canada. steve.prescott@sickkids.ca.
NeuroLinx Research Institute · USUniversity Hospital Münster · DEHospital for Sick Children · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Despite intense research, few treatments are available for most neurological disorders. Demyelinating diseases are no exception. This is perhaps not surprising considering the multifactorial nature of these diseases, which involve complex interactions between immune system cells, glia and neurons. In the case of multiple sclerosis, for example, there is no unanimity among researchers about the cause or even which system or cell type could be ground zero. This situation precludes the development and strategic application of mechanism-based therapies. We will discuss how computational modeling applied to questions at different biological levels can help link together disparate observations and decipher complex mechanisms whose solutions are not amenable to simple reductionism. By making testable predictions and revealing critical gaps in existing knowledge, such models can help direct research and will provide a rigorous framework in which to integrate new data as they are collected. Nowadays, there is no shortage of data; the challenge is to make sense of it all. In that respect, computational modeling is an invaluable tool that could, ultimately, transform how we understand, diagnose, and treat demyelinating diseases.

Indexed as

Computer SimulationModels, BiologicalAxonsDemyelinating DiseasesHumansMultiple SclerosisMyelin SheathNeurodegenerative Diseasescomputational modeldemyelinationdrug discoverymultiple sclerosismyelinneurodegenerative disease

Identifiers

PMID26370960
PMCPMC4613250
OpenAlexW2130399884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.